DeltaGene
Private Company
Funding information not available
Overview
DeltaGene is a private, revenue-generating diagnostics company based in Budapest, Hungary. Its core business is providing direct-to-consumer and clinical genetic testing services, primarily focused on hereditary cancer panels (e.g., BRCA1/2), comprehensive genetic screenings, and supporting targeted cancer therapy decisions. The company leverages its in-house NGS capabilities to offer a range of diagnostic packages, positioning itself in the growing market for preventive and personalized genetic healthcare in Hungary and the surrounding region.
Technology Platform
In-house next-generation sequencing (NGS) capabilities with three NGS platforms. Utilizes targeted gene panels for hereditary cancer (90+ genes), comprehensive genetic screening (up to 20,000 genes), and specific assays for variants common in the Hungarian population.
Opportunities
Risk Factors
Competitive Landscape
Competes with large global genetic testing companies (e.g., Myriad, Invitae) and local diagnostic laboratories in Hungary and the EU. Differentiation is based on local population focus, in-house NGS control, direct-to-consumer packages, and language/cultural specificity.